NO973666L - Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom - Google Patents

Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom

Info

Publication number
NO973666L
NO973666L NO973666A NO973666A NO973666L NO 973666 L NO973666 L NO 973666L NO 973666 A NO973666 A NO 973666A NO 973666 A NO973666 A NO 973666A NO 973666 L NO973666 L NO 973666L
Authority
NO
Norway
Prior art keywords
imaging
contrast
containing liposomes
intravascular compartment
intravascular
Prior art date
Application number
NO973666A
Other languages
English (en)
Other versions
NO973666D0 (no
Inventor
Andreas Sachse
Georg Roessling
Jens Leike
Werner Krause
Gabriele Schuhmann-Giampieri
Peter Muschick
Wolf-Ruediger Press
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO973666D0 publication Critical patent/NO973666D0/no
Publication of NO973666L publication Critical patent/NO973666L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Liposomale kontrastmiddel- preparater for diagnostisk avbildning av intravasalrommet, så vel som deres anvendelse i den bildedannende diagno- stikk.
NO973666A 1995-02-09 1997-08-08 Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom NO973666L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19505813 1995-02-09
PCT/EP1996/000539 WO1996024381A2 (de) 1995-02-09 1996-02-09 Kontrastmittelhaltige liposomen für die darstellung des intravasalraumes

Publications (2)

Publication Number Publication Date
NO973666D0 NO973666D0 (no) 1997-08-08
NO973666L true NO973666L (no) 1997-10-08

Family

ID=7754530

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973666A NO973666L (no) 1995-02-09 1997-08-08 Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom

Country Status (7)

Country Link
EP (1) EP0806969A2 (no)
JP (1) JPH10513466A (no)
AU (1) AU4789096A (no)
CA (1) CA2212162A1 (no)
DE (1) DE19606326A1 (no)
NO (1) NO973666L (no)
WO (1) WO1996024381A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529922A1 (de) * 1995-08-01 1997-02-06 Schering Ag Verwendung von liposomalen Zubereitungen in der indirekten MRT-Lymphographie
GB9624918D0 (en) * 1996-11-29 1997-01-15 Nycomed Imaging As Particulate components
KR100824068B1 (ko) * 2000-04-28 2008-04-21 후지필름 홀딩스 가부시끼가이샤 소수성 요오드 화합물을 함유하는 리포솜
EP1772156A1 (en) * 2004-07-21 2007-04-11 Konica Minolta Medical & Graphic, Inc. Liposome-containing x-ray radiopaque dye and process for producing the same
EP1776948B1 (en) * 2004-08-11 2015-12-09 Konica Minolta Medical & Graphic, Inc. Method of producing liposome-containing preparation
EP2606912A1 (en) * 2011-12-23 2013-06-26 Central Medical Service Co., Ltd. Contrast medium composition with contrast enhancement effect by comprising highly concentrated agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK482685D0 (da) * 1984-10-22 1985-10-21 Hope Nat Medical Center Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
WO1990004943A1 (en) * 1988-11-09 1990-05-17 Unger Evan C Liposomal radiologic contrast agents
DE3922005A1 (de) * 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
DE3934656A1 (de) * 1989-10-13 1991-04-18 Schering Ag Verfahren zur herstellung von waessrigen dispersionen
ATE210426T1 (de) * 1992-10-14 2001-12-15 Liposome Co Inc Interdigitation-fusionsliposomen und gels
EP0665756A1 (de) * 1992-10-16 1995-08-09 SACHSE, Andreas Verfahren und vorrichtung zur herstellung flüssiger, disperser systeme
DE4341472A1 (de) * 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
DE4426438A1 (de) * 1994-07-26 1996-02-01 Schering Ag Verwendung von Chelaten als Röntgenkontrastmittel

Also Published As

Publication number Publication date
WO1996024381A2 (de) 1996-08-15
CA2212162A1 (en) 1996-08-15
WO1996024381A3 (de) 1996-10-03
EP0806969A2 (de) 1997-11-19
JPH10513466A (ja) 1998-12-22
AU4789096A (en) 1996-08-27
DE19606326A1 (de) 1996-08-22
NO973666D0 (no) 1997-08-08

Similar Documents

Publication Publication Date Title
CA2041260A1 (en) Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU6613896A (en) Chemical compounds
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
DE69937076D1 (de) Zwischenprodukte für die Herstellung von Imidazo-Pyridin-Derivate
NO910399L (no) Anvendelse av trialkanolaminpolyetere som demulgatorer for olje-i-vann-emulsjoner.
BR9913225A (pt) Novos agentes antibacterianos de isoxazolinona
AU2001248303A1 (en) Lipid-based systems for targeting diagnostic agents
ES2152511T3 (es) Cepillo de dientes.
NO973666L (no) Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom
ATE207295T1 (de) Fungizide mischungen
DE59610952D1 (de) Einzel-Elektrodensonde für Zweikammer-Herzschrittmachersysteme, insbesondere für DDD-Herzschrittmachersysteme
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
NO980296D0 (no) Forbedrede terapeutiske midler
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69521122T2 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
FI965094A (fi) 2,4,6-trijodi-5-substituoituja aminoisoftalaattiestereitä, jotka ovat hyödyllisiä varjoaineina lääketieteellisessä diagnostisessa kuvauksessa
ATE259379T1 (de) Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung
DE69936052D1 (de) N1 modifizierte glycopeptide
DE69805988D1 (de) Herstellung von 1,3-diaminopentan durch hydrierung von 3-aminopentanitril
NL1000990C2 (nl) Gebitsorgaan.
HRP980066B1 (en) Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them
FI980647A0 (fi) Nytt foerfarande foer diagnostisering av sjukdomar, foer staellande och uteslutande av en differentialdiagnos
IT1285786B1 (it) Disposizione di specchio per lo specchietto esterno di autoveicoli.
NO982186L (no) Anvendelse av gassholdige metallkomplekser som ultralydkontrastmidler
KR970017323U (ko) 에스, 알, 에스 자기 진단장치의 방전구조